Ingrezza
My Prescription
Payment
Select pharmacy
$8,134.59
$30.00 due at pharmacy
$8,134.59 - $30.00 = $8,104.59
$8,104.59 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$8,134.59
Print or send this coupon to your phone
AlbertsonsPowered byAbout Ingrezza
Drug Details
Valbenazine, marketed as Ingrezza, is prescribed to manage involuntary movements, specifically tardive dyskinesia in adults. Additionally, it addresses chorea, which involves random muscle movements seen in adults with Huntington's disease. This medication works by inhibiting the VMAT2 protein in the brain, reducing the levels of certain chemicals like dopamine and serotonin, which are linked to body movements. By lessening these involuntary movements, Valbenazine aids patients in engaging more fully in daily activities. Administered in capsule form, it is typically taken once a day. While effective, it may cause side effects such as sleepiness, fatigue, and other movement-related issues like parkinsonism. Always consult a healthcare professional before starting or changing medication.
Price history for Ingrezza
30 Capsules, 40MG
Average retail price for Ingrezza
Average SaveHealth price for Ingrezza
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Ingrezza dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 40MG | 30 Capsules | $8,134.59 | $271.15 |
| 60MG | 30 Capsules | $8,771.46 | $292.38 |
| 80MG | 30 Capsules | $8,771.46 | $292.38 |
Ingrezza FAQs
Ingrezza is used to treat tardive dyskinesia, a condition characterized by involuntary, repetitive body movements.
The cost of INGREZZA can be attributed to several factors. These include the research and development expenses involved in bringing the medication to market, the costs associated with clinical trials, and the regulatory processes required for approval. Additionally, the pricing may reflect the drug's effectiveness in treating tardive dyskinesia, a condition with limited treatment options. Manufacturing costs, distribution, and the company's pricing strategy also play a role in the overall expense.
The cost of INGREZZA can vary based on factors such as insurance coverage, pharmacy location, and dosage. It is recommended to check with a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may explore patient assistance programs or manufacturer discounts that could help reduce the cost.
Individuals who should not take INGREZZA include those with a known hypersensitivity to valbenazine or any of its components. Additionally, it is important for individuals with certain medical conditions or those taking specific medications to consult with their healthcare provider before starting INGREZZA, as it may not be suitable for everyone. It is crucial to discuss all medical history and current medications with a healthcare professional to determine if INGREZZA is appropriate.
Ingrezza (valbenazine) is primarily used to treat tardive dyskinesia, a condition that can occur as a side effect of certain medications. It is not typically used for Parkinson's disease. Patients with Parkinson's should consult their healthcare provider to determine the most appropriate treatment options for their specific condition.